Search
Now showing items 1-1 of 1
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma
Grunenberg, Alexander et al. (2020)
Wissenschaftlicher Artikel